Deafness Genetics tests in Dubai & UAE

Compare available Deafness Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Deafness Genetics test prices

Showing 1–11 of 11 matching tests.

Deafness Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5624 AIFM1 Gene Deafness, X-Linked Type 5 Genetic Test This genetic test analyzes the AIFM1 gene to identify mutations associated with X-linked deafness type 5 and related auditory neuropathy.	Peripheral whole blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AIFM1 gene variants", "Single nucleotide variants", "Insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No fasting required", "Provide detailed family pedigree", "Provide recent audiology reports"] Indications ["Diagnosis of X-linked deafness type 5 (DFNX5)", "Evaluation of auditory neuropathy spectrum disorder", "Genetic counselling for families with X-linked hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 81294-9 ICD-10: H90.3 Clinical summary This genetic test analyzes the AIFM1 gene to identify mutations associated with X-linked deafness type 5 and related auditory neuropathy.
TEST-5622 CIB2 Gene (Autosomal Recessive Type 48) Genetic Test This test evaluates the CIB2 gene for pathogenic variants associated with autosomal recessive deafness type 48 (DFNB48).	Whole Blood (EDTA tube), Extracted DNA, or FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CIB2 gene"] Parameters [] Preparation ["No medication changes or special preparation needed", "Provide detailed clinical history of hearing loss (onset, severity, family history)"] Indications ["Early intervention for hearing loss", "Carrier screening", "Genetic counseling for hereditary hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 52900-0 ICD-10: H90.5 Clinical summary This test evaluates the CIB2 gene for pathogenic variants associated with autosomal recessive deafness type 48 (DFNB48).
TEST-5618 COL11A2 Gene Deafness (Autosomal Recessive Type 53) Genetic Test This genetic test evaluates the COL11A2 gene for mutations causing autosomal recessive non-syndromic sensorineural hearing loss (DFNB53). It identifies pathogenic variants responsi...	Whole blood (peripheral) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL11A2 gene", "Full exon, splice-site, and promoter coverage"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"] Indications ["Diagnostic confirmation of suspected DFNB53", "Carrier screening for individuals with family history", "Preimplantation genetic testing (PGT) planning", "Cascade screening of at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 21668-3 ICD-10: H90.3 Clinical summary This genetic test evaluates the COL11A2 gene for mutations causing autosomal recessive non-syndromic sensorineural hearing loss (DFNB53). It identifies pathogenic variants responsible for this specific type of hereditary deafness.
TEST-5673 DIABLO Gene (Autosomal Dominant Deafness 64) Genetic Test This genetic test identifies pathogenic variants in the DIABLO gene associated with autosomal dominant nonsyndromic hearing loss type 64.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DIABLO gene variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No fasting required", "Continue prescribed medications unless instructed otherwise"] Indications ["Suspected autosomal dominant nonsyndromic hearing loss type 64 (DFNA64)", "Family history of DFNA64", "Genetic counseling for reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: H90.5 Clinical summary This genetic test identifies pathogenic variants in the DIABLO gene associated with autosomal dominant nonsyndromic hearing loss type 64.
TEST-5691 GJB2 Gene (DFNA3A) Genetic Test This test evaluates the GJB2 gene for variants causing autosomal dominant nonsyndromic hearing loss (DFNA3A).	Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in GJB2 gene", "Small insertions/deletions in GJB2 gene", "Copy number changes in GJB2 gene"] Parameters [] Preparation ["No special preparation is needed.", "Inform phlebotomist of any blood clotting disorders or anticoagulant medications."] Indications ["Diagnosis of autosomal dominant nonsyndromic hearing loss (DFNA3A)", "Genetic counseling for families with hearing loss", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 69549-6 ICD-10: H90.3, Z14.8, Z82.2 Clinical summary This test evaluates the GJB2 gene for variants causing autosomal dominant nonsyndromic hearing loss (DFNA3A).
TEST-5728 GJB3 Gene Autosomal Recessive Deafness Genetic Test This genetic test identifies pathogenic variants in the GJB3 gene associated with autosomal recessive nonsyndromic sensorineural hearing loss.	Blood (Whole Blood), Buccal Swab, or Extracted DNA	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the GJB3 gene", "Connexin 31 protein function"] Parameters [] Preparation [] Indications ["Diagnosis of autosomal recessive nonsyndromic sensorineural hearing loss", "Genetic counselling for families with hearing loss", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 62298-6 ICD-10: H90.3 Clinical summary This genetic test identifies pathogenic variants in the GJB3 gene associated with autosomal recessive nonsyndromic sensorineural hearing loss.
TEST-5749 GJB6 Gene Autosomal Dominant Deafness Type 3B (DFNA3B) Genetic Test This genetic test evaluates the GJB6 gene for pathogenic variants associated with autosomal dominant nonsyndromic hearing loss (DFNA3B).	Peripheral whole blood (EDTA) or buccal swab	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GJB6 gene", "Deletion/duplication analysis of the GJB6 gene"] Parameters [] Preparation ["Inform your doctor of all current medications, supplements, or herbal remedies.", "Do not discontinue any prescribed treatment without consulting your physician."] Indications ["Suspected autosomal dominant nonsyndromic hearing loss (DFNA3B)", "Family screening for GJB6-related hearing loss", "Genetic counseling for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 49211-0 ICD-10: H90.3 Clinical summary This genetic test evaluates the GJB6 gene for pathogenic variants associated with autosomal dominant nonsyndromic hearing loss (DFNA3B).
TEST-5679 ILDR1 Gene Deafness Autosomal Recessive Type 42 Genetic Test (NGS) This test identifies pathogenic variants in the ILDR1 gene associated with non-syndromic sensorineural hearing loss (DFNB42).	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ILDR1 gene", "Coding exons and splice-site regions of ILDR1"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any medications being taken."] Indications ["Diagnosis of non-syndromic hearing loss", "Carrier screening", "Pre-marital risk assessment", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 87409-1 ICD-10: H90.3, Z13.79 Clinical summary This test identifies pathogenic variants in the ILDR1 gene associated with non-syndromic sensorineural hearing loss (DFNB42).
TEST-5606 LHFPL5 Gene Deafness (Autosomal Recessive Type 67) NGS Test This test detects pathogenic variants in the LHFPL5 gene associated with autosomal recessive non-syndromic hearing loss (DFNB67).	Whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LHFPL5 gene", "Presence of mutations causing DFNB67"] Parameters [{"name": "LHFPL5 Gene Sequencing Coverage", "reference_range": "±100×"}, {"name": "NGS Quality Metrics (Q30)", "reference_range": "≥ 85%"}] Preparation ["Mandatory pre-test genetic counseling session", "Bring complete family medical history records", "Signed informed consent form required"] Indications ["Individuals with congenital bilateral sensorineural hearing loss", "Suspected autosomal recessive inheritance pattern", "Exclusion of auditory neuropathy or syndromic features"] Measurement technique Confirm with laboratory Codes LOINC: 93597-4 ICD-10: H90.3 Clinical summary This test detects pathogenic variants in the LHFPL5 gene associated with autosomal recessive non-syndromic hearing loss (DFNB67).
TEST-5692 MYO3A Gene Deafness, Autosomal Recessive Type 30, Genetic Test This genetic test evaluates the MYO3A gene for pathogenic variants associated with autosomal recessive deafness type 30.	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYO3A gene", "Full coding region and splice sites of MYO3A"] Parameters [] Preparation ["Inform phlebotomist about all current medications", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Clinical suspicion of autosomal recessive deafness type 30", "Genetic counselling for families with hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 78582-0 ICD-10: H90.5 Clinical summary This genetic test evaluates the MYO3A gene for pathogenic variants associated with autosomal recessive deafness type 30.
TEST-5600 TRMU Gene Mitochondrial Modifier of Deafness Genetic Test This genetic test evaluates the TRMU gene for pathogenic variants linked to hereditary sensorineural hearing loss.	Peripheral Whole Blood	21 to 28 Days (3 to 4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRMU gene", "Mitochondrial tRNA modification enzyme function"] Parameters [] Preparation [] Indications ["Suspected hereditary sensorineural hearing loss", "Evaluation of mitochondrial-mediated hearing impairment"] Measurement technique Confirm with laboratory Codes LOINC: 82121-5 ICD-10: H90.5, H90.3, Z15.89 Clinical summary This genetic test evaluates the TRMU gene for pathogenic variants linked to hereditary sensorineural hearing loss.

Category overview

Deafness Genetics: overview

Understanding the broader hereditary landscape of auditory health empowers you to make fully informed, proactive decisions for your child’s developmental future. As an expansive offering within our advanced Genetics department, comprehensive Deafness Genetics screening utilizes broad panels to simultaneously evaluate dozens of genes linked to both syndromic and non-syndromic hearing loss. Utilizing cutting-edge diagnostic technology, this robust molecular profiling uncovers elusive genetic drivers, offering the exact clarity required to safely guide specialized multidisciplinary care, proactive vision or thyroid monitoring (for syndromic cases), and customized early intervention therapies. Highly regarded for clinical excellence among diagnostic labs in the UAE, DNA Labs guarantees absolute patient confidentiality, exceptional analytical precision, and remarkably fast turnaround times. Take an empowered step toward targeted support—schedule your deafness genetics testing in UAE, coordinate a secure clinical sample collection, or consult our expert medical team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.